Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Efficacy of INM004 in Children With STEC-HUS
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Inmunova S.A.
- Target Recruit Count
- 220
- Registration Number
- NCT06389474
- Locations
- 🇦🇷
Hospital Interzonal Dr. José Penna, Bahia Blanca, Buenos Aires, Argentina
🇦🇷Hospital de niños Sor María Ludovica, La Plata, Buenos Aires, Argentina
🇦🇷Clinica del niño y la madre, Mar Del Plata, Buenos Aires, Argentina
A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
- Conditions
- Pediatric Kidney DiseaseHemolytic-Uremic SyndromeDiarrhea-Associated Hemolytic Uremic Syndrome
- Interventions
- Other: SoC
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Inmunova S.A.
- Target Recruit Count
- 57
- Registration Number
- NCT05569746
- Locations
- 🇦🇷
Hospital Interzonal Dr. José Penna, Bahía Blanca, Buenos Aires, Argentina
🇦🇷Hospital El Cruce - Néstor Kirchner, Florencio Varela, Buenos Aires, Argentina
🇦🇷Hospital De Niños Sor María Ludovica, La Plata, Buenos Aires, Argentina
Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study
- Conditions
- Covid19
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- Inmunova S.A.
- Target Recruit Count
- 847
- Registration Number
- NCT04954235
- Locations
- 🇦🇷
Hospital de Campaña "Escuela Hogar", Corrientes, Argentina
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Inmunova S.A.
- Target Recruit Count
- 242
- Registration Number
- NCT04494984
- Locations
- 🇦🇷
Hospital de Cuenca Alta, Cañuelas, Buenos Aires, Argentina
🇦🇷Hospital Alta Complejidad "El Cruce" Dr. Néstor Carlos Kirchner, Florencio Varela, Buenos Aires, Argentina
🇦🇷Hospital Prof. Dr. Bernardo A. Houssay, Florida, Buenos Aires, Argentina
Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS
- Conditions
- STEC, UnspecifiedHemolytic-Uremic SyndromeBloody DiarrheaPediatric Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Inmunova S.A.
- Target Recruit Count
- 11
- Registration Number
- NCT04132375
- Locations
- 🇦🇷
Hospital Penna, Bahia Blanca, Buenos Aires, Argentina
🇦🇷Hospital Sor Maria Ludovica, La Plata, Buenos Aires, Argentina
🇦🇷Hospital Lucio Molas, Santa Rosa, LA Pampa, Argentina
- Prev
- 1
- 2
- Next